Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TEVATEVA
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TEVA PHARMACEUTICAL-SP ADR

GOLDMAN SACHS GROUP INC holds 6.1M shares of TEVA (TEVA PHARMACEUTICAL-SP ADR), worth $207.7M as of 2026-Q2. The position was increased (+27.0% shares). TEVA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$207.7M

Current Shares

6.1M

Total Value Change

+$130.1M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.1M
+27.0%
$207.7M0.0%$33.88
38
2026-Q1
Decreased
4.8M
-17.9%
$145.4M0.0%$32.28
0
2025-Q4
Increased
5.9M
+15.6%
$183.5M0.0%$31.34
35
2025-Q3
Increased
5.1M
+4.2%
$102.7M0.0%$19.18
31
2025-Q2
Increased
4.9M
+23.1%
$81.8M0.0%$16.76
36
2025-Q1
Increased
4M
+12.8%
$60.9M0.0%$15.08
33
2024-Q4
New
3.5M
-
$77.5M0.0%$22.32
41

Other major holders of TEVA: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used